Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Microplate Readers Come with Specialty Software

By Drug Discovery Trends Editor | April 24, 2013

Biochrom Ltd. has launched its EZ Read range of microplate readers. Biochrom has created the EZ Read microplate reader range by matching its expertise in absorbance measurement with requests from scientists and technicians to make their experimental workflow easier and more effective. Biochrom’s focus on scientists’ requirements has resulted not only in a dedicated range of instruments but also in the development of unique data acquisition and analysis software; Galapagos for EZ Read.

Measurement of ELISA assays is a major application of absorbance-based microplate readers. Biochrom offers a comprehensive solution for scientists running ELISA assays using Galapagos software’s intuitive ‘click and drag’ approach for setup and analysis, as well as offering a shaker/incubator and a microplate washer to complete the ELISA workflow. Biochrom’s EZ Read range offers the broadest range of ELISA microplate readers so that scientists can choose the right instrument for their unique laboratory environment.

For research scientists, Galapagos software for EZ Read enables quick set up of data analysis making it just as easy to analyze data as to export to Excel. The extensive EZ Read instrumentation range enables scientists to measure all their absorbance assays such as ELISA, total protein and cell viability assays, without the need to buy and install extra filters.

The EZ Read range builds on the success of the EZ Read 400 which was launched in 2011 and is now relied upon by scientists in ELISA labs globally. The EZ Read 800 provides the same reliability and flexibility as the EZ Read 400, but is faster, making it an excellent choice for high throughput labs. The EZ Read LED also provides fast measurements of ELISA assays but uses LEDs for reduced energy consumption and reduced maintenance. For the greatest range of versatility, the EZ Read 2000 has flexible wavelength selection allowing for scientists to choose any wavelength from 340 nm to 800 nm.

Biochrom Ltd.


Filed Under: Drug Discovery

 

Related Articles Read More >

Sai Life Sciences exec: GLP-1 boom has ‘exploded the peptide field’ as firm opens new center
Novartis in the Pharma 50
Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE